Stipple Bio

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to unlock cellular profiling and target discovery. Stipple Bio is based in Cambridge, MA and was founded in 2022. It was valued at $2.2 billion at its early-stage round in Apr 2026, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $65.1 million later-stage round in Mar 2026.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
its early-stage round
Apr 2026
Total raised
$121.5M
Last round
Later Stage VC
Mar 2026

Who backs Stipple Bio?

10 investors
InvestorType
Andreessen HorowitzVenture capital
RA Capital ManagementAsset manager
GVVenture capital
Emerson CollectiveOther
Magnetic VenturesVenture capital
GordonMD Global InvestmentsPE / buyout
Axial (San Francisco)—
Lola Capital Partners—
Nextech Invest—
OMX Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stipple Bio investors

10 investors are on record for Stipple Bio, including Andreessen Horowitz, RA Capital Management, GV and Emerson Collective. By type, the record holds 3 venture capital firms, 1 asset manager and 1 private equity firm. The later-stage round in Mar 2026 drew 15 investors.

Free account
More of Stipple Bio with a free account
  • ·Watch Stipple Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Stipple Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View